An in-silico method for identifying aggregation rate enhancer and mitigator mutations in proteins

作者: Puneet Rawat , Sandeep Kumar , M. Michael Gromiha

DOI: 10.1016/J.IJBIOMAC.2018.06.102

关键词: Folding (chemistry)EnzymeChemistryIn silicoProtein aggregationProtein secondary structureComputational biologyFunction (biology)MutationEnhancer

摘要: Newly synthesized polypeptides must pass stringent quality controls in cells to ensure appropriate folding and function. However, mutations, environmental stresses aging can reduce efficiencies of these controls, leading accumulation protein aggregates, amyloid fibrils plaques. In-vitro experiments have shown that even single amino acid substitutions drastically enhance or mitigate aggregation kinetics. In this work, we collected a dataset 220 unique mutations 25 proteins classified them as enhancers mitigators on the basis their effect rate. The data were analyzed via machine learning identify features capable distinguishing between rate mitigators. Our initial Support Vector Machine (SVM) model separated such with an overall accuracy 69%. When local secondary structures at mutation sites considered, accuracies further improved by 13-15%. machine-learnt are distinct for each structure class sites. Protein stability flexibility changes important α-helices. β-strand propensity, polarity charge become when occur β-strands ability form structure, helical tendency propensity lying coils. These results been incorporated into sequence-based algorithm (available http://www.iitm.ac.in/bioinfo/aggrerate-disc/) predicting whether will protein's This find several applications towards understanding human diseases, enable in-silico optimization biopharmaceuticals enzymes biophysical attributes de novo design bio-nanomaterials.

参考文章(119)
Christopher J. Roberts, Wei Wang, Aggregation of therapeutic proteins : Wiley,. ,(2010)
P. Anoosha, Liang-Tsung Huang, R. Sakthivel, D. Karunagaran, M. Michael Gromiha, Discrimination of driver and passenger mutations in epidermal growth factor receptor in cancer. Mutation Research. ,vol. 780, pp. 24- 34 ,(2015) , 10.1016/J.MRFMMM.2015.07.005
K. Saraboji, M. Michael Gromiha, M.N. Ponnuswamy, Relative importance of secondary structure and solvent accessibility to the stability of protein mutants. Computational Biology and Chemistry. ,vol. 29, pp. 25- 35 ,(2005) , 10.1016/J.COMPBIOLCHEM.2004.12.002
Robert Tycko, Kimberly L. Sciarretta, Joseph P. R. O. Orgel, Stephen C. Meredith, Evidence for Novel β-Sheet Structures in Iowa Mutant β-Amyloid Fibrils Biochemistry. ,vol. 48, pp. 6072- 6084 ,(2009) , 10.1021/BI9002666
R. S. Harrison, P. C. Sharpe, Y. Singh, D. P. Fairlie, Amyloid peptides and proteins in review Reviews of Physiology Biochemistry and Pharmacology. ,vol. 159, pp. 1- 77 ,(2007) , 10.1007/112_2007_0701
Mark A. Hall, Ian H. Witten, Eibe Frank, Data Mining: Practical Machine Learning Tools and Techniques ,(1999)
Rhys Heffernan, Kuldip Paliwal, James Lyons, Abdollah Dehzangi, Alok Sharma, Jihua Wang, Abdul Sattar, Yuedong Yang, Yaoqi Zhou, Improving prediction of secondary structure, local backbone angles, and solvent accessible surface area of proteins by iterative deep learning. Scientific Reports. ,vol. 5, pp. 11476- 11476 ,(2015) , 10.1038/SREP11476
Xiaoling Wang, Tapan K. Das, Satish K. Singh, Sandeep Kumar, Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies mAbs. ,vol. 1, pp. 254- 267 ,(2009) , 10.4161/MABS.1.3.8035
D. Lowe, K. Dudgeon, R. Rouet, P. Schofield, L. Jermutus, D. Christ, Aggregation, stability, and formulation of human antibody therapeutics Advances in Protein Chemistry. ,vol. 84, pp. 41- 61 ,(2011) , 10.1016/B978-0-12-386483-3.00004-5
Annelies Vandersteen, Ellen Hubin, Rabia Sarroukh, Greet De Baets, Joost Schymkowitz, Frederic Rousseau, Vinod Subramaniam, Vincent Raussens, Holger Wenschuh, Dirk Wildemann, Kerensa Broersen, A comparative analysis of the aggregation behavior of amyloid-β peptide variants FEBS Letters. ,vol. 586, pp. 4088- 4093 ,(2012) , 10.1016/J.FEBSLET.2012.10.022